New brain wave test could revolutionize hearing loss diagnosis

NCT ID NCT07091071

Completed Diagnosis Sponsor: University Ghent Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new device called CochSyn that measures brain waves to detect hearing damage. Researchers compared results from 65 adults with and without hearing difficulties. The goal was to see if the device can accurately identify different types of hearing loss and be easy to use in clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COCHLEAR HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autosomal dominant nonsyndromic hearing loss 9 Hearing Loss, Hidden Hearing Loss, Sensorineural sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COCHLEAR HEARING LOSS COCHLEAR SYNAPTOPATHY DFNA9 HEARING LOSS, SENSORINEURAL

Contacts and locations

Locations

CHU de Liège

Liège, Belgium
University Hospital Antwerp (UZA)

Antwerp, Belgium
University Hospital Ghent

Ghent, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.